{
  "type": "hyp",
  "text": "Inhibition of TNF-alpha secretion by LPS-stimulated THP-1-hGH cells was associated with a decrease in nuclear translocation of nuclear factor-kappaB. Electrophoretic mobility shift assay demonstrated that recombinant NF-kappaB and Sp1 complexes bound to the HIV-1 NF-kappaB site in the HIV-1 long terminal repeat.\n",
  "self": {
    "NER": {
      "answers": [
        "TNF",
        "NF-kappaB",
        "HIV-1 NF-kappaB",
        "HIV-1"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What protein secretes more than 80% of the immune system?",
          "What protein is involved in the nuclear translocation of HIV-1?",
          "What site did recombinant NF-kappaB and Sp1 complex",
          "What virus is involved in the recombinant NF-kappaB and"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Inhibition",
        "TNF-alpha secretion",
        "LPS-stimulated THP-1-hGH cells",
        "a decrease",
        "nuclear translocation",
        "nuclear factor-kappaB. Electrophoretic mobility shift assay",
        "recombinant NF-kappaB",
        "complexes",
        "the HIV-1 NF-kappaB site",
        "the HIV-1 long terminal repeat"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What was associated with a decrease in nuclear translocation of nuclear factor-kappaB",
          "What secretion was inhibited by LPS-stimulated THP-1-",
          "What inhibited TNF-alpha secretion?",
          "What was inhibition of TNF-alpha secretion associated with?",
          "What did inhibition of TNF-alpha secretion decrease?",
          "What was shown to decrease nuclear translocation?",
          "What is involved in the cytokine response?",
          "What did the ELISA show to be involved in the decrease in nuclear translocation of",
          "What did recombinant NF-kappaB and Sp1 complexe",
          "Where did recombinant NF-kappaB and Sp1 complexe"
        ]
      }
    }
  },
  "asked": {
    "What is the NF-kappaB site of?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "HIV-1",
        "answerability": 0.9737880229949951,
        "ground_truth": {
          "HIV-1": {
            "bertscore": 1.0,
            "f1": 1.0
          }
        }
      }
    },
    "What subunit is involved in complexes binding to the HIV-1 site?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.493611216545105,
        "ground_truth": {
          "NF-kappaB": {
            "bertscore": 0.6519213318824768,
            "f1": 0
          }
        }
      }
    },
    "What human T-cell has a defective HIV-1?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.003949224948883057,
        "ground_truth": {
          "8e51": {
            "bertscore": 0.6501418352127075,
            "f1": 0
          }
        }
      }
    },
    "What is the name of the study that presents the characterisation of NF-kappa": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.04158979654312134,
        "ground_truth": {
          "this report": {
            "bertscore": 0.659956157207489,
            "f1": 0
          }
        }
      }
    },
    "What is the purpose of this report?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.001470804214477539,
        "ground_truth": {
          "we": {
            "bertscore": 0.6748356223106384,
            "f1": 0
          }
        }
      }
    },
    "What is the purpose of the present study?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0017246007919311523,
        "ground_truth": {
          "the characterisation": {
            "bertscore": 0.6773937940597534,
            "f1": 0
          }
        }
      }
    },
    "What is involved in complexes binding to the HIV-1 NF-kappaB": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.35342955589294434,
        "ground_truth": {
          "NF-kappaB subunits": {
            "bertscore": 0.6328271627426147,
            "f1": 0
          }
        }
      }
    },
    "What are NF-kappaB subunits engaged in?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.005499601364135742,
        "ground_truth": {
          "complexes": {
            "bertscore": 0.6998488306999207,
            "f1": 0
          }
        }
      }
    },
    "What do the NF-kappaB subunits binding to?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "HIV-1 NF-kappaB site",
        "answerability": 0.7173446416854858,
        "ground_truth": {
          "the HIV-1 NF-kappaB site": {
            "bertscore": 0.9441633820533752,
            "f1": 1.0
          }
        }
      }
    },
    "What type of cells harbor a defective HIV-1?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0054891109466552734,
        "ground_truth": {
          "human 8e51 T-cells": {
            "bertscore": 0.592404842376709,
            "f1": 0
          }
        }
      }
    },
    "What do human 8e51 T-cells harbor?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0016571283340454102,
        "ground_truth": {
          "a defective HIV-1": {
            "bertscore": 0.6548319458961487,
            "f1": 0
          }
        }
      }
    }
  }
}